ID1 to 3, but not ID4, were significantly down-regulated with an average decline of 68.7%, 70.2% and 67.7%, respectively, as compared to those of negative control (Figure 4a), supporting that expression of these genes in SLE patients might be regulated by the pathway involving OAZ. Here, ID4 is linked to systemic lupus erythematosus.